Shree Ganesh Remedies executes supply agreement with Japanese firm

31 Jan 2025 Evaluate

Shree Ganesh Remedies (SGRL) has executed long-term Strategic Supply Agreement (SSA) with one of the foremost players in the Japanese market. The agreement, formalised on January 30, 2025, is set for an initial term of three years, with the potential for extension by an additional two years.

Under this strategic partnership, SGRL will engage in contract manufacturing for a total of three innovative products, which are poised to make their debut as the first of their kind in India. These products will be developed employing advanced methodologies in Chlorination and Reduction chemistry.

Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.

Shree Ganesh Remed. Share Price

445.05 -9.80 (-2.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×